Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Decision-tree Approach to Stratify DLBCL Risk Based on Stromal and Immune Microenvironment Determinants.
Zaccaria GM, Vegliante MC, Mezzolla G, Stranieri M, Volpe G, Altini N, Gargano G, Pappagallo SA, Bucci A, Esposito F, Opinto G, Clemente F, Negri A, Mondelli P, De Candia MS, Bevilacqua V, Guarini A, Ciavarella S. Zaccaria GM, et al. Among authors: guarini a. Hemasphere. 2023 Apr 5;7(4):e862. doi: 10.1097/HS9.0000000000000862. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37038464 Free PMC article. No abstract available.
Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort.
Minoia C, Diella L, Perrone T, Loseto G, Pelligrino C, Attolico I, Pasciolla C, Totaro V, De Candia MS, Spada V, Clemente F, Camporeale M, Di Gennaro F, Guarini A, Musto P, Saracino A, Bavaro DF. Minoia C, et al. Among authors: guarini a. Br J Haematol. 2023 Sep;202(5):928-936. doi: 10.1111/bjh.18895. Epub 2023 May 31. Br J Haematol. 2023. PMID: 37259629
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML.
Negri A, Ward C, Bucci A, D'Angelo G, Cauchy P, Radesco A, Ventura AB, Walton DS, Clarke M, Mandriani B, Pappagallo SA, Mondelli P, Liao K, Gargano G, Zaccaria GM, Viggiano L, Lasorsa FM, Ahmed A, Di Molfetta D, Fiermonte G, Cives M, Guarini A, Vegliante MC, Ciavarella S, Frampton J, Volpe G. Negri A, et al. Among authors: guarini a. Cell Death Dis. 2023 Nov 23;14(11):763. doi: 10.1038/s41419-023-06276-z. Cell Death Dis. 2023. PMID: 37996430 Free PMC article.
Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences.
Rossini B, Cecchi N, Clemente F, De Paolis MR, Hohaus S, Innao V, Lucignano M, Massaiu R, Palumbo G, Rigolin GM, Rossi FG, Verga L, Guarini A. Rossini B, et al. Among authors: guarini a. Drugs Context. 2024 Mar 12;13:2023-9-4. doi: 10.7573/dic.2023-9-4. eCollection 2024. Drugs Context. 2024. PMID: 38510313 Free PMC article.
Effects of victimization and perpetration in observing bullying scenes: an eye-tracker study{es}: Efectos de la victimización y la perpetración en la observación de escenas de acoso: un estudio con eye-tracker.
Menabò L, Caravita SCS, Skrzypiec G, Slee P, Guarini A. Menabò L, et al. Among authors: guarini a. Int J Clin Health Psychol. 2024 Apr-Jun;24(2):100451. doi: 10.1016/j.ijchp.2024.100451. Epub 2024 Feb 28. Int J Clin Health Psychol. 2024. PMID: 38439799 Free PMC article.
Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL.
Foà R, Bassan R, Elia L, Piciocchi A, Soddu S, Messina M, Ferrara F, Lunghi M, Mulè A, Bonifacio M, Fracchiolla N, Salutari P, Fazi P, Guarini A, Rambaldi A, Chiaretti S. Foà R, et al. Among authors: guarini a. J Clin Oncol. 2024 Mar 10;42(8):881-885. doi: 10.1200/JCO.23.01075. Epub 2023 Dec 21. J Clin Oncol. 2024. PMID: 38127722 Free PMC article.
447 results